Mitochondrial ROS microdomains and neuronal ischemia

线粒体 ROS 微区和神经元缺血

基本信息

  • 批准号:
    9059782
  • 负责人:
  • 金额:
    $ 33.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Reactive oxygen species (ROS) contribute to a diverse range of neurodegenerative diseases and the pathology of acute injuries such as stroke in mammals. However, not all ROS are equal, and the disease output depends strongly on the timing and location of ROS production. Furthermore, ROS in limited quantities have been shown to trigger adaptive signaling pathways and may contribute to mitohormesis. These facts lead to our central hypothesis that the biological impact of ROS, like other second messengers, depends on their timing, quantity and site of generation. However, due to their reactive nature, there is currently no means to control the site or timing of ROS production. This proposal addresses this gap by combining novel photo- inducible genetically-encoded ROS generating proteins with the power of C. elegans genetics to determine the evolutionarily-conserved role of ROS signaling in the context of neuronal ischemic sensitivity and stress resistance. In brief, new optogenetic tools for making ROS will be expressed as protein fusions using CRISPR/Cas9 technology with nuclear genes that encode mitochondrial respiratory chain subunits. The proposal focuses on the complex II subunit SDHC and utilizes expertise in biosensors, the model organism C. elegans, and optics to study ROS signaling with an unprecedented degree of precision. Parallel approaches utilizing cortical neurons in culture will address the evolutionarily conserved role of mitochondrial ROS in regulating neuronal sensitivity to ischemia. This approach could potentially yield new therapeutic strategies for diseases in which redox homeostasis has been disrupted. Overall, this novel approach will advance our understanding of mitochondrial redox signaling, allowing us to ask questions that have previously been unanswerable using conventional methodologies.
 描述(由申请人提供):活性氧物种(ROS)有助于多种神经退行性疾病和哺乳动物急性损伤(如中风)的病理。然而,并不是所有的ROS都是相等的,疾病的产出强烈地依赖于ROS产生的时间和地点。此外,有限数量的ROS已被证明可以触发适应性信号通路,并可能有助于有丝分裂。这些事实导致了我们的中心假设,即ROS像其他第二信使一样,其生物学影响取决于它们的时间、数量和发生地点。然而,由于其反应性,目前还没有办法控制ROS生产的地点或时间。这一建议通过将新颖的光诱导遗传编码的ROS产生蛋白与线虫遗传学的力量相结合来解决这一差距,以确定ROS信号在神经元缺血敏感性和应激抵抗中的进化保守作用。简而言之,制造ROS的新的光遗传工具将表现为使用CRISPR/Cas9技术与编码线粒体呼吸链亚基的核基因的蛋白质融合。该提案侧重于复杂的II亚基SDHC,并利用生物传感器、模式生物线虫和光学方面的专业知识,以前所未有的精度研究ROS信号。利用培养的皮质神经元的平行方法将解决线粒体ROS在调节神经元对缺血的敏感性方面在进化上的保守作用。这种方法可能会为氧化还原动态平衡被破坏的疾病产生新的治疗策略。总体而言,这种新的方法将促进我们对线粒体氧化还原信号的理解,使我们能够提出以前使用传统方法无法回答的问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew Phillip Wojtovich其他文献

Andrew Phillip Wojtovich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew Phillip Wojtovich', 18)}}的其他基金

Mitochondrial Energy Sensing and Neuronal Ischemia
线粒体能量感应和神经元缺血
  • 批准号:
    10524047
  • 财政年份:
    2020
  • 资助金额:
    $ 33.58万
  • 项目类别:
Mitochondrial Energy Sensing and Neuronal Ischemia
线粒体能量感应和神经元缺血
  • 批准号:
    10090662
  • 财政年份:
    2020
  • 资助金额:
    $ 33.58万
  • 项目类别:
Mitochondrial Energy Sensing and Neuronal Ischemia
线粒体能量感应和神经元缺血
  • 批准号:
    10318080
  • 财政年份:
    2020
  • 资助金额:
    $ 33.58万
  • 项目类别:
Mitochondrial ROS microdomains and neuronal ischemia
线粒体 ROS 微区和神经元缺血
  • 批准号:
    9277588
  • 财政年份:
    2015
  • 资助金额:
    $ 33.58万
  • 项目类别:
Mitochondrial ROS microdomains and neuronal ischemia
线粒体 ROS 微区和神经元缺血
  • 批准号:
    10198294
  • 财政年份:
    2015
  • 资助金额:
    $ 33.58万
  • 项目类别:
Mitochondrial ROS microdomains and neuronal ischemia
线粒体 ROS 微区和神经元缺血
  • 批准号:
    10552598
  • 财政年份:
    2015
  • 资助金额:
    $ 33.58万
  • 项目类别:
Mitochondrial ROS microdomains and neuronal ischemia
线粒体 ROS 微区和神经元缺血
  • 批准号:
    10337338
  • 财政年份:
    2015
  • 资助金额:
    $ 33.58万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了